ANACOR PHARMACEUTICALS, INC.

PALO ALTO, CA How do I update this listing?

Anacor Pharmaceuticals is based out of Palo Alto. Anacor Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing small-molecule therapeutics derived from its boron chemistry platform.Whalewisdom has at least 1 13G filings, and 185 Form 4 filings The firm last filed a Form D notice of exempt offering of securities on 2013-06-17. The notice included securities offered of Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security,Other

Create Alert

Contact Info

anacor pharmaceuticals, inc.
1020 E. MEADOW CIRCLE
PALO ALTO CA    94303

Business Phone: 650-543-7500
SEC SIC CODE:
2834-PHARMACEUTICAL PREPARATIONS

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Loading...

Form D Filings

Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date Form Type Industry Group Securities Offered Total Offering Amount Total Amount Sold Total Remaining
2013-06-17 D PHARMACEUTICALS Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security,Other 2,700,000 0 2,700,000
2013-04-09 D PHARMACEUTICALS Equity 5,000,000 5,000,000 0
2011-03-31 D PHARMACEUTICALS Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security,Other 1,650,000 0 1,650,000
2010-12-03 D PHARMACEUTICALS Equity 10,000,000 10,000,000 0
Other Issuers in Filings
Name Address
No Other Issuers
Related Parties included in filings
Name Address Relationship
ANDERS HOVE subscription required
    DIRECTOR
DAVID PERRY subscription required
    EXECUTIVE OFFICER DIRECTOR
GEOFFREY PARKER subscription required
    EXECUTIVE OFFICER
IRWIN HEYMAN subscription required
    EXECUTIVE OFFICER
JACOB PLATTNER subscription required
    EXECUTIVE OFFICER
KIRK MAPLES subscription required
    EXECUTIVE OFFICER
LEE ZANE subscription required
    EXECUTIVE OFFICER
LUCY SHAPIRO subscription required
    DIRECTOR
MARK LESCHLY subscription required
    DIRECTOR
PAUL BERNS subscription required
    DIRECTOR
PAUL KLINGENSTEIN subscription required
    DIRECTOR
RICHARD MARKHAM subscription required
    DIRECTOR
SANJAY CHANDA subscription required
    EXECUTIVE OFFICER
WILLIAM RIEFLIN subscription required
    DIRECTOR
ZHI HONG subscription required
    DIRECTOR

Elevate your investments